The anthrapyrazoles

被引：18

作者：

Gogas, H ^{[1
]}

Mansi, JL ^{[1
]}

机构：

[1] ST GEORGE HOSP,DEPT ONCOL,LONDON SW17 0QT,ENGLAND

来源：

CANCER TREATMENT REVIEWS | 1995年 / 21卷 / 06期

关键词：

D O I：

10.1016/0305-7372(95)90017-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：541 / 552

页数：12

共 55 条

[31]

INGLE JN, 1994, CANCER, V74, P1733, DOI 10.1002/1097-0142(19940915)74:6<1733::AID-CNCR2820740615>3.0.CO

[32]

2-D

[33] A PHASE-II TRIAL OF PIROXANTRONE IN ADENOCARCINOMA OF THE PANCREAS - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].

JENKINS, TR ;

TANGEN, C ;

MACDONALD, JS ;

WEISS, G ;

CHAPMAN, R ;

HANTEL, A .

INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) :329-331

[34]

KLOHS WD, 1986, CANCER RES, V46, P4352

[35]

KOCHA W, 1992, P AM SOC CLIN ONCOL, V11, P306

[36]

LEOPOLD WR, 1985, CANCER RES, V45, P5532

[37]

LIAO ST, 1986, SIBR8502 US DEP COMM

[38] DIMINISHED SUPEROXIDE ANION GENERATION BY REDUCED 5-IMINODAUNORUBICIN RELATIVE TO DAUNORUBICIN AND THE RELATIONSHIP TO CARDIOTOXICITY OF THE ANTHRACYCLINE ANTI-TUMOR AGENTS .18. [J].

LOWN, JW ;

CHEN, HH ;

PLAMBECK, JA ;

ACTON, EM .

BIOCHEMICAL PHARMACOLOGY, 1979, 28 (17) :2563-2568

[39]

LOWN JW, 1983, MOL CELL BIOCHEM, V55, P17, DOI 10.1007/BF00229240

[40] PHASE-II STUDY ON DUP-937 (TELOXANTRONE) IN COLORECTAL-CARCINOMA - A CANADIAN-NATIONAL-CANCER-INSTITUTE CLINICAL-TRIAL GROUP-STUDY [J].

MAROUN, JA ;

SKILLINGS, J ;

MACCORMICK, R ;

POTVIN, M ;

WIELGOSZ, G ;

DAVIDSON, JR ;

EISENHAUER, E .

INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) :235-237

← 1 2 3 4 5 6 →